Table 1 Comparison of demographic data and vascular risk factors in the bleeding and non‐bleeding groups.
Characteristic | sICH | No sICH | Total | p Value |
---|---|---|---|---|
Sex, n = 294 | ||||
Men | 7 | 154 | 54.8% | 0.787* |
Women | 7 | 126 | 45.2% | |
Age, years (mean (SD)) | 63 (12) | 60 (13) | 60 (13) | 0.338† |
NIHSS on admission | 16 (7.00) | 15 (8.75) | 15 (8.00) | 0.507† |
Arterial hypertension, n = 293 | ||||
Yes | 9 | 150 | 54.3% | 0.585* |
No | 5 | 129 | 45.7% | |
Hyperlipidaemia, n = 293 | ||||
Yes | 3 | 98 | 34.5% | 0.393* |
No | 11 | 181 | 65.5% | |
Smoking, n = 293 | ||||
Yes | 3 | 63 | 22.5% | 1.000* |
No | 11 | 216 | 77.5% | |
Family history of CVE, n = 226 | ||||
Yes | 3 | 55 | 25.7% | 0.697* |
No | 6 | 162 | 74.3% | |
History of CVE, n = 294 | ||||
Yes | 2 | 36 | 12.9% | 0.699* |
No | 12 | 244 | 87.1% | |
Diabetes mellitus, n = 293 | ||||
Yes | 3 | 37 | 13.7% | 0.417* |
No | 11 | 242 | 86.3% | |
Blood pressure on admission (mm Hg) | n = 10 | n = 184 | n = 194 | |
Systolic | 145 (65) | 145 (39) | 145 (40) | 0.832† |
Diastolic | 92.5 (22.5) | 80 (20) | 80 (20) | 0.040† |
Aspirin or clopidogrel before IAT, n = 198 | ||||
Yes | 5 | 35 | 20.2% | 0.164* |
No | 9 | 149 | 79.8% | |
Vitamin K antagonist before IAT, n = 293 | ||||
Yes | 1 | 6 | 2.4% | 0.293* |
No | 13 | 273 | 97.6% |
CVE, cerebrovascular ischaemic event; IAT, intra‐arterial thrombolysis; sICH, symptomatic intracranial haemorrhage.
Numbers in parentheses are interquartile ranges, unless specified otherwise.
*Fisher's exact test.
†Mann–Whitney U test.